cjc 1295 5mg ipamorelin 5mg dosage per day daily dose blend 5 cjc 1295 no dac ipamorelin dosage CJC 1295 No Dac (5mg) + Ipamorelin (10mg) cjc-1295 + CJC 1295 Peptide Guide |

The peptide amplifies the natural GH pulsatile release pattern rather than creating artificial spikes

Peptide Vials (Glutathione, 600 mg each): 4 weeks (100150 mg/day avg) 3 vials 8 weeks (150200 mg/day avg) 7 vials Insulin Syringes (U-100): Per week: 7 syringes (1/day) 4 weeks: 28 syringes 8 weeks: 56 syringes Bacteriostatic Water (10 mL bottles): Use ~2.0 mL per vial for reconstitution

Tirzepatide: GLP-1 + GIP (Dual Agonist) Tirzepatide activates two receptors

Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas

Restoration of the somatotropic axis with preserved pulsatility (P 800 cumulative) Tesamorelin Chemical Identity Stabilized synthetic analogue of human GHRH (44 amino acids) Tesamorelin Clinical Tolerability Safety profile evaluated in Phase III clinical trials in humans Published Clinical Data Phase III randomized controlled clinical trials published in NEJM and JAMA 15.2% Reduction of visceral adipose tissue at 26 weeks (2 mg SC/day vs placebo) Results at 26 Weeks 18% Reduction of visceral and hepatic fat at 12 months 12-Month Results Important Notice Search Only Not intended for human consumption